Braveheart Bio, Inc. <BRVE.O>: TD Cowen initiates coverage with buy rating
BRVE•Related News
Malibu Boats corrects Q4 adjusted EBITDA to USD 31.39 million after acquisition cost error
MBUU•
Kazia Therapeutics launches registered public offering of ADSs and warrants
KZIA•
Aon strikes $17 billion deal for rival USI Insurance Services
AON•
Alamos Gold director Claire Kennedy exits board after Canada consul general appointment
AGI•
Schmid Group CFO Arthur Schuetz acquires 15,200 shares for $49,096
SHMD•